entertainment -WSS

entertainment

author：comprehensive 2025-10-01 20:14:27 - browse：4932

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： FDA seeks to regulate lab

WSS

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Second xenotransplant done with gene

Covid vaccines: Private market messier than government rollout

Covid vaccines: Private market messier than government rollout

Senator probes 340B programs at Cleveland Clinic, Bon Secours

hotspot

entertainment

hotspot

Affirmative action in medical school literally saved lives

Inequities make cancer less preventable for women: report

In Memoriam: Notable people who died in 2023

Microbiome research is starting to find links to chronic diseases

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Menendez indictment could see pharma lose a key ally

Medical records are filled with copy

Lasker Awards 2023: Winners in biomedical research

Novavax promises a turnaround & Lilly roils the obesity market

Menendez indictment could see pharma lose a key ally

Wikipedia

Why do women spend more than men on medical expenses?

What Congress can do to address the rural doctor shortage

FDA panel to weigh approval of NurOwn, controversial ALS drug

Readout LOUD podcast: possible new ALS drug, artificial wombs

Ionis has late

Would Medicare drug price negotiations stall in a shutdown?

leisure time

entertainment

leisure time

hotspot